The Food and Drug Administration has dropped its final guidance document for sponsors and investigators wishing to implement decentralized clinical trials, which can be run remotely to make participation more convenient.
A decentralized clinical trial (DCT) is one that occurs at locations other than traditional clinical trial sites. As the final document — “